4.0 Review

Nanofabrication and microfabrication of functional materials for tissue engineering

期刊

TISSUE ENGINEERING
卷 13, 期 8, 页码 1867-1877

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ten.2006.0198

关键词

-

资金

  1. NCI NIH HHS [CA119349] Funding Source: Medline
  2. NHLBI NIH HHS [HL076485-01, HL060435] Funding Source: Medline
  3. NIBIB NIH HHS [EB002520-01, EB003647, P41 EB002520] Funding Source: Medline
  4. NIDCR NIH HHS [DE16516, DE13023] Funding Source: Medline

向作者/读者索取更多资源

The burgeoning field of regenerative medicine promises significant progress in the treatment of cardiac ischemia, liver disease, and spinal cord injury. Key to its success will be the ability to engineer tissue safely and reliably. Tissue functionality must be recapitulated in the laboratory and then integrated into surrounding tissue upon transfer to the patient. Scaffolding materials must be chosen such that the microenvironment surrounding the cells is a close analog of the native environment. In the early days of tissue engineering, these materials were largely borrowed from other fields, with much of the focus on biocompatibility and biodegradation. However, attention has shifted recently to cell- cell and cell- surface interactions, largely because of enabling technologies at the nanoscale and microscale. Studies on cellular behavior in response to various stimuli are now easily realized by using microfabrication techniques and devices ( e. g., biomedical microelectromechanical systems). These experiments are reproducible and moderate in cost, and often can be accomplished at high throughput, providing the fundamental knowledge required to design biomaterials that closely mimic the biological system. It is our opinion that these novel materials and technologies will bring engineered tissues one step closer to practical application in the clinic. This review discusses their application to cardiac, liver, and nerve tissue engineering.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据